ÂÜŔňÂŇÂ×

C. Michael Gibson, M.S., M.D., pioneered their understanding of the open artery and the open microvasculature hypothesis in the setting of heart attack. As an innovator, Dr. Gibson invented measures of coronary blood flow that are widely used today.

A practicing interventional cardiologist, cardiovascular researcher, and educator, Dr. Gibson is also the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School. In 2021, he was named one of the Fifty of the Most Influential Voices in Healthcare by Medika Life. He founded and is the Editor-in-Chief of WikiDoc.org and WikiPatient.org, widely viewed open source textbooks of medicine.

Dr. Gibson has led phase 1-4 clinical trials, and cardiology megatrials which eventuate in international approval of life-saving drugs and devices. He is currently leading the HEARTLINE trial of the Apple Watch, the first large “Virtual” randomized trial which will enroll up to 180,000 patients—one of the largest randomized patient trials in history.

Dr. Gibson obtained his BS, MS, and MD degrees at the University of Chicago, did his internship, residency, and chief residency at the Brigham and Women’s Hospital and his cardiology fellowship at the Beth Israel Deaconess Medical Center, both at Harvard Medical School.